1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Oesophageal cancer

Bemarituzumab with chemotherapy for untreated inoperable HER2-negative advanced gastric or gastro-oesophageal junction cancer ID6481

Awaiting development [GID-TA11607] Expected publication date: TBC

  • Project information
  • Project documents

26965-Bemarituzumab-Chemotherapy-for-Gastric-or-Gastro-Oesophageal-Junction-Cancer-V1.0-JUNE2024-NON-CONF.pdf (nihr.ac.uk)